FDA approves first gene therapy for Duchenne muscular dystrophy聽
The Food and Drug Administration June 22 the first gene therapy to treat patients aged 4-5 with a confirmed mutation in the Duchenne muscular dystrophy gene. As part of the drug鈥檚 accelerated , the drugmaker must conduct additional clinical trials to verify the predicted clinical benefit.
Related News Articles
Headline
Nearly 57% of mothers did not attend a postpartum follow-up visit three to eight weeks after giving birth, according to a report published July 29 by Cedar鈥
Headline
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,鈥
Headline
The Joint Commission July 29 announced an initiative to address 鈥済aps鈥 in how children鈥檚 hospitals are accredited and certified. The program will remove or鈥
Headline
The AHA July 24 announced it is collaborating with health care technology leader Epic to help hospitals adopt tools that support the early detection and鈥
Headline
A Health Affairs study on the decline of obstetric services in rural and urban hospitals nationwide from 2010-2022 found that seven states had at least 25% of鈥
Headline
The latest video in the AHA鈥檚 series 鈥淢edicaid: Real Lives, Real Care鈥 features Melissa Fannon-Wisner, DNP, nurse educator and nurse practitioner at Valley鈥